Please assess the completion status of the following clinical trial:

Trial Title: A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Clinical diagnosis of NASH as assessed by MRI~* Clinically documented diagnosis of T2DM~* Body mass index (BMI) \>25 kg/m2~Exclusion Criteria:~* Liver disease unrelated to NASH~* Poorly controlled T2DM or Type 1 Diabetes Mellitus~* History of alcohol or substance abuse or dependence~* Inability to undergo MRI for any reason~* History of significant cardiovascular disease

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- 500mg HTD1801, bid (Type: EXPERIMENTAL): None
- 1000mg HTD1801, bid (Type: EXPERIMENTAL): None
- placebo, bid (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).